Search results for "Musca"

showing 10 items of 300 documents

Cognitive and mood side effects of lower urinary tract medication

2019

Introduction: Muscarinic receptor antagonists, 5α-reductase inhibitors and α1-adrenoceptor antagonists are frequently used drug classes for the treatment of lower urinary tract symptoms including those of overactive bladder syndrome and benign prostatic enlargement/benign prostatic obstruction. Areas covered: The authors review the evidence for adverse effects of these drug classes on cognitive function, mood and other functions of the central nervous system and discuss such effects against the evidence for mechanistic plausibility. Expert opinion: Muscarinic antagonists carry a risk for impaired cognition and other brain functions that differs quantitatively between compounds, being highes…

MaleTamsulosinmedicine.medical_specialtyUrinary systemProstatic HyperplasiaMuscarinic Antagonists030204 cardiovascular system & hematology03 medical and health sciences5-alpha Reductase InhibitorsCognition0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsTamsulosinInternal medicinemedicineAnimalsHumansDementiaPharmacology (medical)OxybutyninAdverse effectDose-Response Relationship DrugUrinary Bladder Overactivebusiness.industryGeneral Medicinemedicine.diseaseDiscontinuationAffectMood030220 oncology & carcinogenesisAdrenergic alpha-1 Receptor Antagonistsbusinessmedicine.drugExpert Opinion on Drug Safety
researchProduct

Regioisomeric 5(3)-aminomethyl-3(5)-phenylisoxazoles: synthesis, spectroscopic discrimination, and muscarinic activity.

1995

The regioselective synthesis of isomeric 5(3)-aminomethyl-3(5)-phenyl isoxazoles using different methods is described. Spectroscopic data, especially mass spectrometric fragmentation, were used to identify and characterize the regioisomers. The muscarinic activity of these isoxazoles was assayed on isolated guinea-pig ileum and atria as well as on isolated rabbit vas deferens. Regioisomere 5(3)-Aminomethyl-3(5)-phenyl-isoxazole: Synthese, spektroskopische Unterscheidung und muskarinische Aktivitat Es werden verschiedene Verfahren zur regioselektiven Darstellung von 5(3)-Aminomethyl-3(5)-phenyl-isoxazolen beschrieben, die anhand ihrer spektroskopischen Daten, insbesondere der massenspektrosk…

MaleTertiary amineStereochemistryChemistryGuinea PigsVas deferensCholinergic AgentsPharmaceutical ScienceMuscle SmoothIn Vitro TechniquesChemical synthesisMass spectrometricMyocardial Contractionmedicine.anatomical_structureVas DeferensIleumDrug DiscoveryMuscarinic acetylcholine receptorStructural isomermedicineAnimalsRabbitsOxazolesMuscle ContractionArchiv der Pharmazie
researchProduct

A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis

2012

Abstract Context Nocturia is a common urologic symptom that has been covered in a variety of reported studies in the literature but is not specifically covered in current guidelines. Objective To comprehensively review the literature pertaining to the definition, etiologies, and consequences of nocturia and assess the evidence supporting the use of conservative medical and interventional therapy. Evidence acquisition A literature search was conducted using the keyword nocturia , restricted to articles in the English language, after 2000 and before April 2012, in PubMed/Medline, Embase, Scopus, Web of Science, and Cochrane Library databases. Regarding treatment modalities, studies were inclu…

MaledesmopressinPathologyAnti-Inflammatory AgentsCochrane Libraryurologic and male genital diseaseslaw.inventionsystematic reviewRandomized controlled trialRisk FactorslawEpidemiologyOdds RatioPrevalencea1-blockersDesmopressina1-blockers; alpha(1)-blockers; antimuscarinics; desmopressin; meta-analysis; nocturia; nocturnal polyuria; systematic review; α1-blockersEvidence-Based MedicineAntidiuretic AgentsDiagnostic Techniques UrologicalMiddle AgedPathophysiologyfemale genital diseases and pregnancy complicationsTreatment OutcomeMeta-analysisUrologic Surgical ProceduresFemaleNocturiaα1-blockersmedicine.symptommedicine.drugmedicine.medical_specialtyUrologyMEDLINEMuscarinic Antagonistsalpha(1)-blockersPredictive Value of TestsInternal medicinemedicineHumansNocturiaIntensive care medicineantimuscarinicsAgedChi-Square Distributionbusiness.industrynocturnal polyuriaEvidence-based medicinemeta-analysisClinical trialUrodynamicsEndocrinologyAdrenergic alpha-1 Receptor AntagonistsbusinessEuropean urology
researchProduct

Cholinergic and GABAergic regulation of nitric oxide synthesis in the guinea pig ileum.

1999

Nitric oxide (NO) synthesis was examined in intact longitudinal muscle-myenteric plexus preparations of the guinea pig ileum by determining the formation of [3H]citrulline during incubation with [3H]arginine. Spontaneous [3H]citrulline production after 30 min was 80–90 dpm/mg, which constituted ∼1% of the tissue radioactivity. Electrical stimulation (10 Hz) led to a threefold increase in [3H]citrulline formation. Removal of calcium from the medium or addition of N G-nitro-l-arginine strongly inhibited both spontaneous and electrically induced production of [3H]citrulline. TTX reduced the electrically induced but not spontaneous [3H]citrulline formation. The electrically induced formation o…

Malemedicine.medical_specialtyBaclofenArgininePhysiologyGuinea PigsScopolamineMyenteric PlexusTubocurarineTetrodotoxinBiologyCholinergic AgonistsIn Vitro TechniquesMecamylamineBicucullineNitric OxideNitroarginineCholinergic Antagonistschemistry.chemical_compoundIleumPhysiology (medical)Internal medicineIsometric ContractionMuscarinic acetylcholine receptorMecamylaminemedicineCitrullineAnimalsEgtazic AcidGABA AgonistsMyenteric plexusgamma-Aminobutyric AcidHepatologyGABAA receptorMuscimolOxotremorineGastroenterologyMuscle SmoothBicucullineElectric StimulationEndocrinologychemistryMuscimolCitrullineFemalemedicine.drugThe American journal of physiology
researchProduct

Different muscarinic receptors mediate autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat isolated perfused heart

1990

Experiments were carried out on rat isolated perfused hearts with both vagus nerves attached. The acetylcholine stores were labelled with [14C]-choline. The effects of muscarinic receptor antagonists on the [14C]-overflow and increase in perfusion pressure evoked by vagus nerve stimulation (10 Hz, 4-10 mA) were studied in order to determine the muscarinic receptor type involved in autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat heart. Stimulation of the vagus nerves (1200 pulses) caused an increase in [14C]-overflow and in perfusion pressure which was significantly reduced by hexamethonium 500 mumol/l and abolished by tetrodotoxin 0.3 mumol/l or perfu…

Malemedicine.medical_specialtyBlood PressureIn Vitro Techniqueschemistry.chemical_compoundInternal medicineMuscarinic acetylcholine receptorMethoctramineMuscarinic acetylcholine receptor M4medicineAnimalsPharmacologyMyocardiumParasympatholyticsMuscarinic acetylcholine receptor M3HeartRats Inbred StrainsVagus NerveMuscarinic acetylcholine receptor M2General MedicineMuscarinic acetylcholine receptor M1Receptors MuscarinicAcetylcholineElectric StimulationRatsVagus nervePerfusionEndocrinologynervous systemchemistryVasoconstrictionAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Gastric relaxation induced by apigenin and quercetin: Analysis of the mechanism of action

2009

Abstract Aims Recently, flavonoids have been shown to cause murine gastric relaxation. In the present study we examined the mechanism of action underlying gastric relaxation induced by apigenin and quercetin in isolated mouse stomach. Main methods The mechanical activity from the whole stomach was detected as changes in the endoluminal pressure and the response to increasing concentrations of both flavonoids were tested before and after different pharmacological treatments. Key findings Apigenin and quercetin-induced a concentration-dependent gastric relaxation, apigenin being more potent than quercetin. The responses were unaffected by 2′5′dideoxyadenosine, an inhibitor of adenylate cyclas…

Malemedicine.medical_specialtyCarbacholNifedipineMuscle Relaxationchemistry.chemical_elementCalcium antagonistIn Vitro TechniquesMuscarinic AgonistsCalciumPharmacologySettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologyPotassium ChlorideMicechemistry.chemical_compoundSmooth muscleInternal medicineCyclic AMPmedicineAnimalsheterocyclic compoundsApigeninGeneral Pharmacology Toxicology and PharmaceuticsCyclic GMPCyclic nucleotide phosphodiesteraseChemistryRyanodine receptorStomachMuscle SmoothGeneral MedicineCalcium Channel BlockersMice Inbred C57BLEndocrinologyMechanism of actionGastric toneApigeninFlavonoidCalciumCarbacholQuercetinmedicine.symptomQuercetinIntracellularMuscle Contractionmedicine.drugLife Sciences
researchProduct

In vitro tracheal hyperresponsiveness to muscarinic receptor stimulation by carbachol in a rat model of bleomycin-induced pulmonary fibrosis

2006

Summary 1 Bleomycin-induced lung injury is widely used as an experimental model to investigate the pathophysiology of pulmonary fibrosis but the alterations in the pharmacological responsiveness of airways isolated from bleomycin-exposed animals has been scarcely investigated. The aim of this study was to examine the in vitro tracheal responses to muscarinic receptor stimulation with carbachol in a rat bleomycin model. 2 Concentration–response curves to carbachol (10 nm to 0.1 mm) were obtained in tracheal rings isolated from Sprague–Dawley rats 14 days after endotracheal bleomycin or saline. The intracellular calcium signal in response to carbachol (10 μm) was measured by epifluorescence m…

Malemedicine.medical_specialtyCarbacholPulmonary FibrosisStimulationIn Vitro TechniquesMuscarinic AgonistsLung injuryCalcium in biologyProinflammatory cytokineRats Sprague-DawleyBleomycinFibrosisInternal medicinePulmonary fibrosisMuscarinic acetylcholine receptormedicineAnimalsCalcium SignalingPharmacologyDose-Response Relationship DrugTumor Necrosis Factor-alphabusiness.industryMuscle Smoothrespiratory systemmedicine.diseaseReceptors MuscarinicRatsTracheaDisease Models AnimalEndocrinologyCarbacholBronchial HyperreactivitybusinessInterleukin-1Muscle Contractionmedicine.drugAutonomic and Autacoid Pharmacology
researchProduct

Apparent vs real effects of scopolamine on the learning of an active avoidance task.

1996

The effects of scopolamine hydrobromide (0.5 and 2 mg/ kg) administered intraperitoneally to Balb/c male mice before or after training in active avoidance were explored in four training sessions and in a subsequent test session, free of drug. Animals given scopolamine prior to training performed better than controls, an effect that was reversed in the session free of drug. However, a deeper analysis of the data permits us to interpret this increment in the number of avoidance responses as a consequence of the increase in activity produced by the drug and not as learning. In the animals injected with scopolamine after sessions no effects were observed. In conclusion, the results of the prese…

Malemedicine.medical_specialtyCognitive NeuroscienceScopolamineMale miceExperimental and Cognitive PsychologyAudiologyTask (project management)Developmental psychologyBehavioral NeuroscienceMicePharmacokineticsMuscarinic acetylcholine receptorTask Performance and AnalysisScopolaminemedicineAvoidance LearningAnimalsMice Inbred BALB CDose-Response Relationship DrugAntagonistBiological activityPsychologyNeuroscienceScopolamine Hydrobromidemedicine.drugNeurobiology of learning and memory
researchProduct

Angiotensin II contractile effects in mouse colon: role for pre- and post-junctional AT1A receptors

2013

Aim This study investigates whether a local renin–angiotensin system (RAS) exists in mouse colon and whether angiotensin II (Ang II) may play a role in the regulation of the contractile activity. Methods Isometric recordings were performed in vitro on the longitudinal muscle of mouse proximal and distal colon. Transcripts encoding for RAS components were investigated by RT-PCR. Results Ang II caused, in both preparations, a concentration-dependent contractile effect, antagonized by losartan, AT1 receptor antagonist, but not by PD123319, AT2 receptor antagonist. The combination of losartan plus PD123319 caused no change on the Ang II-induced contraction than losartan alone. Tetrodotoxin, neu…

Malemedicine.medical_specialtyColonPhysiologymedicine.drug_classMuscarinic AntagonistsBiologyReceptor Angiotensin Type 1Renin-Angiotensin SystemMicechemistry.chemical_compoundOrgan Culture TechniquesInternal medicineMuscarinic acetylcholine receptormedicineAnimalsReceptorAngiotensin II receptor type 1Reverse Transcriptase Polymerase Chain ReactionAngiotensin IIAntagonistMuscle Smoothangiotensin II AT1 receptors AT2 receptors enteric neurones mouse colon muscle contraction.Receptor antagonistAngiotensin IIElectrophysiologyMice Inbred C57BLEndocrinologyLosartanchemistryHexamethoniumhormones hormone substitutes and hormone antagonistsMuscle Contractionmedicine.drug
researchProduct

Antagonist discrimination between subtypes of tachykinin receptors in the guinea-pig ileum.

1986

1. The effects of substance P and eledoisin on spontaneous and electrically-evoked release of [3H]acetylcholine, and on smooth muscle were studied in the guineapig myenteric plexus-longitudinal muscle preparation preloaded with [3H]choline. Substance P and eledoisin caused transient increases in spontaneous release of [3H]acetylcholine and in longitudinal muscle tone. Both tachykinins were equipotent in contracting the muscle, but eledoisin was more potent than substance P in eliciting [3H]acetylcholine release. The release caused by substance P was enhanced in the presence of naloxone and scopolamine which suggests that the release is modulated through opioid and muscarinic receptors. 2. S…

Malemedicine.medical_specialtyEledoisinGuinea PigsScopolamineSubstance P(+)-NaloxoneSubstance Pcomplex mixtureschemistry.chemical_compoundEledoisinIleumInternal medicineMuscarinic acetylcholine receptormedicineAnimalsNeurotransmitterReceptorReceptors TachykininPharmacologyNaloxoneGeneral MedicineAcetylcholineReceptors NeurotransmitterEndocrinologychemistryFemaleTachykinin receptorAcetylcholinemedicine.drugMuscle ContractionNaunyn-Schmiedeberg's archives of pharmacology
researchProduct